Question.4329 - Discussion Thread: Disease ProcessIn this week's discussion, we will begin to tie the body systems studied thus far together. Moreover, we will see the effects of disease on the systems studied and thoughtfully consider how science equips humans to participate in God’s redemptive work.Research a disease process of your choice. Choose a disease process that involves at least three organ systems — the effect of the disease on these systems must be detailed in the initial discussion board post.Choose your disease early — no more than 2 students may cover the same disease! You can "claim" your disease as early as the first week by starting a thread that only has a subject heading for your disease. Then post your thread that includes the following outlined items as a reply to your own subject heading. If two of your classmates have already posted the subject heading for a certain disease, such as Diabetes Mellitus, you will need to choose a different disease process. The following items must be included in your initial thread:Indicate the disease to be discussed.Describe disease process, including common symptoms and the effect on three organ systems.Discuss treatment and management of the disease.Describe how science equips humans to participate in God’s redemptive work.Please review the Discussion Assignment Instructions Download Discussion Assignment Instructionsprior to posting. You may also click the three dots in the upper corner to Show Rubric.Submit your thread by 11:59 p.m. (ET) on Thursday of Module 6: Week 6.
Answer Below:
Multiple xxxxx systems xxx affected xx Systemic xxxxx Erythematosus xxx a xxxxxxx autoimmune xxxxxxx characterized xx extensive xxxxxxxxxxxx and xxxxxx destruction xxxxxxx on xx the xxxxxx system xxxxxxxxx its xxx tissues xxxxx are xxxxxxxxx affected xxxxxxxxxxxx when xxxx are xxxxxxx Mayo xxxxxx Disease xxxxxxx and xxxxxxx on xxxxx Organ xxxxxxxxxx musculoskeletal xxxxx and xxxxxxxxxxxxx systems xxx frequently xxxxxxxx by xxx Integumentary xxxxxx SLE xxxxxxxxxx presents xx photosensitivity xxx the xxxxxxxxxxx butterfly xxxx on xxx face xxxx ulcers xxx hair xxxx are xxxx possible xxxxxxxxxxxxxxx system xxxx individuals xxxx rheumatoid xxxxxxxxxxxxxx joint xxxx arthralgia xxxxxxxxx and xxxxx Joint xxxxxxxxxxxxx may xxxxxx from xxxxxx SLE xxxxx system xxxxx of xxxxxxxxxxx develop xxxxx nephritis xx inflammation xx the xxxxxxx If xxxx untreated xxxxxx complexes xxx accumulate xx the xxxxxxxxx and xxxxxx renal xxxxxxxxxx leading xx kidney xxxxxxx Tsokos xxxxxxxxx and xxxxxxxxxxxxx goal xx managing xxx is xx inhibit xxx hyperactive xxxxxx response xxx reduce xxxxxxxxxxxx even xxxxxx there xx no xxxxx cure xxxxx the xxxxxxxxxx are xxxxxxxxxxx include xxxxxxxxxxxxxxxxx substances xxxx as xxxxxxxxxxxxx mofetil xx hydroxychloroquine xxxxxxxxxxxxxxx for xxxxxxxxx and xxxxxxxxxxxx anti-inflammatory xxxxxxxxxxx NSAIDs xxx pain xxx inflammation xxxxxxxxx changes xxxxxxx stress xxxxxxxxx frequent xxxxxxxx and xxx protection xxxxxxxxxx It xx critical xx perform xxxxxxx renal xxxxxxxx testing xxx keep xx eye xxx for xxxxxxxxxxxxxx issues xxxxxxx and xxx s xxxxxxxxxx WorkBy xxxxxxxxx compassionate xxxx reducing xxxxxxxxx and xxxxxxxxx medical xxxxxxxx science xxxxxxx everyone xx take xxxx in xxxxx redemptive xxxxxxx B-cell xxxxxxxxxx and xxxxx biologic xxxxxxx advancements xxxx significantly xxxxxxxx patient xxxxxxxx in xxx Additionally xxxxx intervention xxx individualized xxxxxxxxx approaches xxx made xxxxxxxx by x knowledge xx the xxxxxxx and xxxxxxxxxxxxx triggers xxx SLE xxxxxx Isenberg xxxxx efforts xx restore xxxxxx and xxxxxxx to xxxxxxxxxxx afflicted xx illness xxx a xxxxxxxxxx of xxxxxxxxxx responsibilities xx stewards xx God's xxxxxxxx ReferencesMayo xxxxxx n x Systemic xxxxx erythematosus xxx Retrieved xxxx https xxx mayoclinic xxxxxxxx to xx external xxxx Tsokos x C xxxxxxxx lupus xxxxxxxxxxxxx New xxxxxxx Journal xx Medicine x Rahman x Isenberg x A xxxxxxxx lupus xxxxxxxxxxxxx New xxxxxxx Journal xx Medicine xMore Articles From BIOL102 Principles of Human Biology (D03)
.ico)
.ico)
.ico)
.ico)
